Condition: Warts · Sponsor: Western Institute for Veterans Research
This double-blinded clinical trial randomly assigns participants with refractory cutaneous warts to receive either treatment with the human papillomavirus (HPV) vaccine or a placebo to assess the efficacy of HPV vaccination for the treatment of refractory cutaneous warts.
This description comes directly from the study's public registry record.
Lowell Nicholson, MD · 801-581-2121 · lowell.nicholson@hsc.utah.edu
Jamie Rhoads, MD · 801-581-2121 · jamie.rhoads@hsc.utah.edu
Always discuss trial participation with your own doctor first.
| University of Utah Midvalley Health Center | Salt Lake City, Utah, United States | Recruiting |
| VA Salt Lake City Health Care System | Salt Lake City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05625633